Jul. 13, 2026
LONE TREE, COLORADO — Cochlear Limited (ASX: COH) today announced FDA clearance of the new Cochlear® Osia® 3 Sound Processor, the latest generation of its Osia® bone conduction hearing system.‡ Cochlear’s bone conduction hearing solutions are designed for children and adults with conductive hearing loss, mixed hearing loss, and single-sided deafness (SSD). Key Features of the Osia 3 Sound Processor

















